SI0986387T1 - FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER - Google Patents

FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER

Info

Publication number
SI0986387T1
SI0986387T1 SI9830404T SI9830404T SI0986387T1 SI 0986387 T1 SI0986387 T1 SI 0986387T1 SI 9830404 T SI9830404 T SI 9830404T SI 9830404 T SI9830404 T SI 9830404T SI 0986387 T1 SI0986387 T1 SI 0986387T1
Authority
SI
Slovenia
Prior art keywords
inhibitors
cancer
treatment
combination
coa reductase
Prior art date
Application number
SI9830404T
Other languages
Slovenian (sl)
Inventor
Shama Mohammed Kajiji
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Priority claimed from PCT/IB1998/000881 external-priority patent/WO1998057633A1/en
Publication of SI0986387T1 publication Critical patent/SI0986387T1/en

Links

SI9830404T 1997-06-16 1998-06-05 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER SI0986387T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4963897P 1997-06-16 1997-06-16
PCT/IB1998/000881 WO1998057633A1 (en) 1997-06-16 1998-06-05 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
EP98921688A EP0986387B1 (en) 1997-06-16 1998-06-05 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER

Publications (1)

Publication Number Publication Date
SI0986387T1 true SI0986387T1 (en) 2003-10-31

Family

ID=29252312

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830404T SI0986387T1 (en) 1997-06-16 1998-06-05 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER

Country Status (1)

Country Link
SI (1) SI0986387T1 (en)

Similar Documents

Publication Publication Date Title
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
AP9700939A0 (en) Compounds and methods for the treatment of cancer
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2265895A (en) Inhibition of liver cancer by the use of gnrh and gnrh analogs
UA66793C2 (en) Leptin as inhibitor of tumor growth
HRP980328B1 (en) FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
GB9315846D0 (en) Tumour inhibitors
NO20005680L (en) Combinations of protein farnesyl transferase and HMG CoA reductase inhibitors and their use in the treatment of cancer
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL134592A0 (en) Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
SI0986387T1 (en) FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
EP1086261A4 (en) An anticorrosion treatment
EP1135141A4 (en) Phospholipase inhibitors for the treatment of cancer
AU2002303182A1 (en) Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the inhibition for the treatment of cancer
AU8492598A (en) Methods and compositions for tumor reduction
AU7130696A (en) Combination of beta-interferon for the treatment of prostate cancer
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors